Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
8.78
-0.39 (-4.25%)
Market open: Aug 12, 2026, 12:26 PM EDT
9.18
+0.01 (0.11%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
There is no data to display
| Date | Type | Document |
|---|---|---|
| 2026-08-12 | 8-K | ef20079835_8k.htm |
| 2026-08-11 | 10-Q | ef20076330_10q.htm |
| 2026-08-03 | 8-K | ef20079264_8k.htm |
| 2026-07-31 | 8-K | ef20079178_8k.htm |
| 2026-07-01 | S-3ASR | ny20076823x1_s3asr.htm |
| 2026-05-22 | 8-K | ny20074564x2_8k.htm |
| 2026-05-13 | 8-K | ef20072992_8k.htm |
| 2026-05-12 | 10-Q | ef20070434_10q.htm |
| 2026-04-29 | 8-K | ef20071159_8k.htm |
| 2026-04-23 | 8-K | ef20070365_8k.htm |